Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹167 Cr₹31 Cr₹-217 Cr₹-165 Cr₹-250 Cr

What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Financing Activities ratio of ORCHID PHARMA is ₹167 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹167 Cr
Mar2023₹31 Cr
Mar2022₹-217 Cr
Mar2021₹-165 Cr
Mar2020₹-250 Cr

How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹167 Cr
435.97
Mar2023 ₹31 Cr
Positive
Mar2022 ₹-217 Cr
Negative
Mar2021 ₹-165 Cr
Negative
Mar2020 ₹-250 Cr -

Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,599.7 Cr -1.4% 1% -48% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.4%

1%

-48%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses